Policy Statement on Antimicrobial Stewardship by the Society for Healthcare Epidemiology of America (SHEA), the Infectious Diseases Society of America (IDSA), and the Pediatric Infectious Diseases Society (PIDS)
Policy Statement on Antimicrobial Stewardship by the Society for Healthcare Epidemiology of America (SHEA), the Infectious Diseases Society of America (IDSA), and the Pediatric Infectious Diseases Society (PIDS)
复制标题
DOI：
10.1086/665010
复制
发表时间：
2012-04-01
影响因子：
4.5
通讯作者：
Newland, Jason
中科院分区：
文献类型：
--
作者：
Fishman, Neil;Patterson, Jan;Newland, Jason
在21世纪，抗菌素耐药性已经成为一个重要的医疗质量和患者安全问题，再加上抗菌药机构的迅速减少，已经导致对美国公共卫生的严重威胁。抗菌药物管理计划优化了抗菌药物的使用，以实现最佳的临床结果，同时将不良事件降至最低，并限制了导致耐药性出现的选择压力，还可能减少因次优抗菌药物使用而导致的过高成本。因此，抗菌药物管理必须是整个护理过程中所有医疗机构的受托责任。美国卫生保健流行病学学会、美国传染病学会和美国儿科传染病学会的这份立场声明概述了在整个卫生保健过程中强制实施抗微生物药物管理的建议，提出了监测这些干预措施的过程和结果措施，并解决了这一领域的教育和研究不足以及美国缺乏关于抗微生物药物使用的准确数据的问题。感染控制猪瘟2012；33(4)：322-327
Antimicrobial resistance has emerged as a significant healthcare quality and patient safety issue in the twenty-first century that, combined with a rapidly dwindling antimicrobial armamentarium, has resulted in a critical threat to the public health of the United States. Antimicrobial stewardship programs optimize antimicrobial use to achieve the best clinical outcomes while minimizing adverse events and limiting selective pressures that drive the emergence of resistance and may also reduce excessive costs attributable to suboptimal antimicrobial use. Therefore, antimicrobial stewardship must be a fiduciary responsibility for all healthcare institutions across the continuum of care. This position statement of the Society for Healthcare Epidemiology of America, the Infectious Diseases Society of America, and the Pediatric Infectious Diseases Society of America outlines recommendations for the mandatory implementation of antimicrobial stewardship throughout health care, suggests process and outcome measures to monitor these interventions, and addresses deficiencies in education and research in this field as well as the lack of accurate data on antimicrobial use in the United States. Infect Control Hosp Epidemiol 2012; 33(4): 322-327